Nasivin Vicks Kids (Oxymetazoline Hydrochloride)

Oxymetazoline, the active ingredient in Nasivin Vicks Kids, is an alpha‑adrenergic agonist presented as a nasal spray for nasal use. It provides temporary relief of nasal congestion caused by the common cold, allergic rhinitis or sinusitis in children.

GNH USA supplies Nasivin Vicks Kids as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline nasal spray works on the nasal mucosa to relieve congestion associated with several upper‑respiratory conditions. - Common cold: temporary reduction of nasal blockage and swelling. - Allergic rhinitis: alleviation of congestion caused by seasonal or perennial allergies. - Sinusitis: helps clear nasal passages during acute sinus inflammation.

Oxymetazoline nasal spray may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Sneezing shortly after administration. - Dryness of the nasal mucosa. - Mild headache. - Transient taste disturbance.

Serious or Rare Side Effects: - Persistent nasal congestion (rebound congestion) after prolonged use. - Elevated blood pressure in susceptible individuals. - Palpitations or tachycardia. - Severe allergic reaction (rash, swelling, difficulty breathing).

Before using Oxymetazoline nasal spray, consider the following safety points. - Age restriction: not recommended for children under the age specified on the label. - Cardiovascular disease: avoid if you have uncontrolled hypertension or heart disease. - Diabetes: use with caution as systemic absorption may affect blood glucose control. - Concurrent nasal decongestants: do not combine with other topical decongestants to prevent excess vasoconstriction. - Prolonged use: limit to the duration indicated to avoid rebound congestion. - Store below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Oxymetazoline may interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Sympathomimetic drugs (e.g., pseudoephedrine): additive vasoconstrictive effects.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood‑pressure‑lowering effect. - Tricyclic antidepressants: may enhance cardiovascular stimulation. - Beta‑blockers: monitor for increased heart rate or blood pressure changes.